← Leaderboards
Joshua T. Mattila
University Of Pittsburgh At Pittsburgh
$2,064,710
Attributed
$4,943,238
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,943,238 · 5
By mechanism
R01$4,008,040 · 2
R21$833,398 · 2
F32$101,800 · 1
Top collaborators
- Bryan David Bryson6 shared
- Cory Michael Robinson4 shared
- Christina Leigh Stallings2 shared
- Lokesh Kumar Sharma1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joanne L. Flynn$43,717,509
- Philana Ling Lin$10,232,778
- Eric Joseph Rubin$20,208,402
- Charles A. Scanga$10,882,031
- Cory Michael Robinson$4,487,425
Others in their field
Top investigators on “Granuloma”
- William Ramses Bishai · Johns Hopkins University$27,911,517
- Deepak Kaushal · University Of Chicago$25,352,082
- Joanne L. Flynn · University Of Pittsburgh At Pittsburgh$24,805,814
- Lalita Ramakrishnan · Stanford University$16,324,683
- Shabaana A. Khader · University Of Chicago$15,278,589
- John R. Chan · Rutgers Biomedical And Health Sciences$15,161,867
Research focus
GranulomaResponseMacrophageMycobacterium TuberculosisTuberculosisCellsInfectionT-LymphocytePharmaceutical PreparationsBacteriaImmunityMacacaAntimycobacterial AgentsImmuneTissuesCell CommunicationHiv/TbNonhuman PrimatePersonsLinkInnovationAffectPathogenesisPredisposition
Grant awards (11)
Type I IFN-dependent and independent contributions to the outcomes of early innate immune cell interactions during HIV/TB co-infection$872,144
R01 · FY2025 · AI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$544,872
R01 · FY2025 · AI · contact PI
Identifying a protective role for interferon lambda in tuberculosis$413,002
R21 · FY2025 · AI · contact PI
Type I IFN-dependent and independent contributions to the outcomes of early innate immune cell interactions during HIV/TB co-infection$899,894
R01 · FY2024 · AI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$539,481
R01 · FY2024 · AI · contact PI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$603,802
R01 · FY2023 · AI · contact PI
Evaluating macrophage antiviral immunity as a suppressive factor in SIV-M. tuberculosis co-infection$193,115
R21 · FY2023 · AI · contact PI
Elucidating the mechanisms and consequences of MDSC-regulated immunity in TB$547,847
R01 · FY2022 · AI · contact PI
Evaluating macrophage antiviral immunity as a suppressive factor in SIV-M. tuberculosis co-infection$227,281
R21 · FY2022 · AI · contact PI
Reactivated tuberculosis in SIV-infected cynomolgus macaques$52,154
F32 · FY2010 · AI · contact PI
Reactivated tuberculosis in SIV-infected cynomolgus macaques$49,646
F32 · FY2009 · AI · contact PI